Skip to main content
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.62
+0.12 (2.18%)
Mar 28, 2025, 4:00 PM EDT - Market closed

TriSalus Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
29.4318.5112.48.45.43
Revenue Growth (YoY)
58.99%49.31%47.58%54.60%-
Cost of Revenue
4.12.612.261.192.2
Gross Profit
25.3315.9110.147.213.24
Selling, General & Admin
43.8140.5525.2217.0213.06
Research & Development
17.6929.5121.3614.2215.83
Operating Expenses
61.4970.0646.5831.2428.88
Operating Income
-36.17-54.15-36.44-24.03-25.65
Interest Expense
-3.09-0.02-0-1.76-6.04
Interest & Investment Income
0.40.430.18--
Other Non Operating Income (Expenses)
-2.42-15.59-10.92-0.46-0.14
EBT Excluding Unusual Items
-41.27-69.32-47.18-26.25-31.83
Other Unusual Items
11.2310.29--2.59-
Pretax Income
-30.04-59.03-47.18-28.84-31.83
Income Tax Expense
0.010.010.0100
Net Income
-30.05-59.04-47.19-28.85-31.83
Preferred Dividends & Other Adjustments
3.194.242.83--
Net Income to Common
-33.23-63.28-50.02-28.85-31.83
Shares Outstanding (Basic)
259098
Shares Outstanding (Diluted)
259098
Shares Change (YoY)
169.61%2934.71%-96.51%15.52%-
EPS (Basic)
-1.31-6.73-161.55-3.25-4.15
EPS (Diluted)
-1.31-6.73-161.55-3.25-4.15
Free Cash Flow
--50.63-32.97-23.79-16.13
Free Cash Flow Per Share
--5.39-106.48-2.68-2.10
Gross Margin
86.06%85.93%81.79%85.80%59.55%
Operating Margin
-122.88%-292.53%-293.91%-286.06%-471.95%
Profit Margin
-112.92%-341.84%-403.42%-343.35%-585.76%
Free Cash Flow Margin
--273.53%-265.91%-283.23%-296.74%
EBITDA
-35.43-53.45-36.04-23.57-25.33
EBITDA Margin
-120.38%-288.74%-290.70%-280.54%-
D&A For EBITDA
0.730.70.40.460.32
EBIT
-36.17-54.15-36.44-24.03-25.65
EBIT Margin
-122.88%-292.53%-293.91%-286.06%-
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q